TRILC.E — Turk Ilac ve Serum Sanayi AS Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapContrarian

Annual income statement for Turk Ilac ve Serum Sanayi AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	R2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	673	1,637	2,774	3,355	4,539
Cost of Revenue
Gross Profit	120	354	631	1,049	1,599
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	597	1,463	2,393	2,651	3,348
Operating Profit	75.8	174	382	704	1,191
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	46.9	-9.67	119	129	-511
Provision for Income Taxes
Net Income After Taxes	37.1	-81.7	153	94.7	-623
Net Income Before Extraordinary Items
Net Income	37.1	-81.7	153	94.7	-623
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	37.1	-81.7	153	94.7	-623
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.227	-0.504	0.943	0.603	-3.85
Dividends per Share